BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 18579604)

  • 1. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
    Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
    J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium.
    Sheahan T; Rockx B; Donaldson E; Sims A; Pickles R; Corti D; Baric R
    J Virol; 2008 Mar; 82(5):2274-85. PubMed ID: 18094188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus.
    Wu K; Peng G; Wilken M; Geraghty RJ; Li F
    J Biol Chem; 2012 Mar; 287(12):8904-11. PubMed ID: 22291007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.
    Rockx B; Sheahan T; Donaldson E; Harkema J; Sims A; Heise M; Pickles R; Cameron M; Kelvin D; Baric R
    J Virol; 2007 Jul; 81(14):7410-23. PubMed ID: 17507479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.
    Liu L; Fang Q; Deng F; Wang H; Yi CE; Ba L; Yu W; Lin RD; Li T; Hu Z; Ho DD; Zhang L; Chen Z
    J Virol; 2007 May; 81(9):4694-700. PubMed ID: 17314167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
    He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S
    J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.
    Song HD; Tu CC; Zhang GW; Wang SY; Zheng K; Lei LC; Chen QX; Gao YW; Zhou HQ; Xiang H; Zheng HJ; Chern SW; Cheng F; Pan CM; Xuan H; Chen SJ; Luo HM; Zhou DH; Liu YF; He JF; Qin PZ; Li LH; Ren YQ; Liang WJ; Yu YD; Anderson L; Wang M; Xu RH; Wu XW; Zheng HY; Chen JD; Liang G; Gao Y; Liao M; Fang L; Jiang LY; Li H; Chen F; Di B; He LJ; Lin JY; Tong S; Kong X; Du L; Hao P; Tang H; Bernini A; Yu XJ; Spiga O; Guo ZM; Pan HY; He WZ; Manuguerra JC; Fontanet A; Danchin A; Niccolai N; Li YX; Wu CI; Zhao GP
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2430-5. PubMed ID: 15695582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.
    Qu XX; Hao P; Song XJ; Jiang SM; Liu YX; Wang PG; Rao X; Song HD; Wang SY; Zuo Y; Zheng AH; Luo M; Wang HL; Deng F; Wang HZ; Hu ZH; Ding MX; Zhao GP; Deng HK
    J Biol Chem; 2005 Aug; 280(33):29588-95. PubMed ID: 15980414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody.
    Ng OW; Keng CT; Leung CS; Peiris JS; Poon LL; Tan YJ
    PLoS One; 2014; 9(7):e102415. PubMed ID: 25019613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
    Zhu Z; Chakraborti S; He Y; Roberts A; Sheahan T; Xiao X; Hensley LE; Prabakaran P; Rockx B; Sidorov IA; Corti D; Vogel L; Feng Y; Kim JO; Wang LF; Baric R; Lanzavecchia A; Curtis KM; Nabel GJ; Subbarao K; Jiang S; Dimitrov DS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12123-8. PubMed ID: 17620608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
    Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
    Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
    Becker MM; Graham RL; Donaldson EF; Rockx B; Sims AC; Sheahan T; Pickles RJ; Corti D; Johnston RE; Baric RS; Denison MR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19944-9. PubMed ID: 19036930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.
    Lau SK; Feng Y; Chen H; Luk HK; Yang WH; Li KS; Zhang YZ; Huang Y; Song ZZ; Chow WN; Fan RY; Ahmed SS; Yeung HC; Lam CS; Cai JP; Wong SS; Chan JF; Yuen KY; Zhang HL; Woo PC
    J Virol; 2015 Oct; 89(20):10532-47. PubMed ID: 26269185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.
    Li W; Zhang C; Sui J; Kuhn JH; Moore MJ; Luo S; Wong SK; Huang IC; Xu K; Vasilieva N; Murakami A; He Y; Marasco WA; Guan Y; Choe H; Farzan M
    EMBO J; 2005 Apr; 24(8):1634-43. PubMed ID: 15791205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission.
    Bolles M; Donaldson E; Baric R
    Curr Opin Virol; 2011 Dec; 1(6):624-34. PubMed ID: 22180768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.
    Deming D; Sheahan T; Heise M; Yount B; Davis N; Sims A; Suthar M; Harkema J; Whitmore A; Pickles R; West A; Donaldson E; Curtis K; Johnston R; Baric R
    PLoS Med; 2006 Dec; 3(12):e525. PubMed ID: 17194199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.